Skip to main content
Clinical Trials/NCT03952884
NCT03952884
Completed
Not Applicable

Skeletal Muscle Protein Synthetic Response to Amino Acid and Peptides

University of Illinois at Urbana-Champaign1 site in 1 country10 target enrollmentMay 3, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Protein Metabolism
Sponsor
University of Illinois at Urbana-Champaign
Enrollment
10
Locations
1
Primary Endpoint
Fractional Synthetic Rate of Myofibrillar Proteins
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Skeletal muscle quality is an important determinant of exercise performance and overall health. It is vital for not just movement, but also metabolizing nutrients. Protein from the diet can promote muscle protein synthesis for muscle recovery and growth. More importantly, doing so shifts net protein balance positively (e.g. protein synthesis is greater than protein breakdown) and promotes greater rates of muscle protein turnover. Leucine is an amino acid required to build muscle, but it also acts as a signaling molecule informing the muscle to start protein synthesis. Before reaching skeletal muscle, dietary protein is digested into small peptides and free amino acids. Rate of absorption from the intestine to the blood stream is significantly faster for peptides compared to amino acids. As amino acid availability in the blood is a precursor for muscle protein synthesis, our objective is to determine if the different absorption rates between free amino acid and peptides influence muscle protein synthetic and breakdown rates.

Registry
clinicaltrials.gov
Start Date
May 3, 2019
End Date
November 20, 2019
Last Updated
5 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Nicholas Burd

Assistant Professor

University of Illinois at Urbana-Champaign

Eligibility Criteria

Inclusion Criteria

  • Recreationally-active adults: ≥ 30 min of physical activity at moderate intensity ≥ 3 times per week
  • Ages: 18-35 years old
  • English fluency

Exclusion Criteria

  • Tobacco, nicotine (patch/gum) use (previous 6 mo)
  • Alcohol consumption \>10 drinks per week
  • Metabolic disorders (e.g., Metabolic Syndrome, Diabetes, thyroid diseases)
  • Cardiovascular disease, arrhythmias
  • Hypogonadism
  • History of uncontrolled hypertension
  • Orthopedic injury/surgery (within 1 yr)
  • Hepatorenal, musculoskeletal, autoimmune, or neurological disease
  • History of neuromuscular problems
  • Previous participation in amino acid tracer studies

Outcomes

Primary Outcomes

Fractional Synthetic Rate of Myofibrillar Proteins

Time Frame: Postabsorptive for 3.5 hours, Postprandial for 3 hours.

Myofibrillar muscle protein synthesis rates will be assessed during the 3.5hr Postabsorptive period (e.g. non-fed state) and the 3hr postprandial period (e.g. fed state) for both experimental interventions (e.g. leucine and leucine peptide). This will allow us to assess the change in fractional synthetic rate from the Postabsorptive period to the postprandial period.

Fractional Synthetic Rate of Mixed Muscle Proteins

Time Frame: Postabsorptive for 3.5 hours, Postprandial for 3 hours.

Mixed muscle protein synthesis rates will be assessed during the 3.5hr Postabsorptive period (e.g. non-fed state) and the 3hr postprandial period (e.g. fed state) for both experimental interventions (e.g. leucine and leucine peptide). This will allow us to assess the change in fractional synthetic rate from the Postabsorptive period to the postprandial period.

Fractional Breakdown Rate of Mixed Muscle Proteins

Time Frame: Postprandial for 1 hour

Mixed muscle protein breakdown rates will be assessed during the first hour of the postprandial period (e.g. fed state) for both experimental interventions (e.g. leucine and leucine peptide). This will allow us to assess the change in fractional breakdown rate for each respective experimental intervention.

Secondary Outcomes

  • Phosphorylation of muscle anabolic signaling(Baseline, immediately after ingestion of leucine/leucine peptides, and 3 hours after ingestion of leucine/leucine peptides)

Study Sites (1)

Loading locations...

Similar Trials